USING PHARMACOVIGILANCE DATA TO SUPPORT A LIFECYCLE APPROACH FOR REGULATING VETERINARY DRUGS - A CANADIAN APPROACH
31 / 31
Authors
-
Heather Aitken
Pharmacovigilance Evaluator,Veterinary Drugs Directorate, Health Canada Ottawa, Ontario, Canada
Abstract
Nil
Downloads
References
Food and Drug Regulations, Part C, Division 1, Adverse Reaction Reporting (C.01.016), C.R.C., c.870; Food and Drug Regulations, Part C, Division 8, New Drugs (C.08.007, C.08.008), C.R.C., c. 870; Natural Health Products Regulations, Section 24, Reaction Reporting, C.R.C., SOR/2003-196.
Regulation (EU) No.1235/2010 of the European Parliament and of the Council of 15 December 2010;
Lindquist M. Vigibase, the WHO Global ICSR Database System: Basic Facts. Drug Information Journal , 2008, 42:409-419.
Geneva, WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems, World Health Organization, 2004
Downloads
Submitted
Published
Issue
Section
License
All the copy right belongs to the sponsoring Organization, Tamil Nadu Veterinary and Animal Sciences University, Chennai - 51.
How to Cite
